Der-Torossian, Hirak
Mayo Clinic
From the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (R.Y.); Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill (J.W.); Sarah Cannon Research Institute, Tennessee Oncology, Nashvill
Citations 1
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
Yaeger, Rona , Weiss, Jared, Pelster, Meredith , Leal, Ticiana , Bekaii‐Saab, Tanios , Heavey, Grace A., Christensen, James G. , Velastegui, Karen , Kheoh, Thian , Der‐Torossian, Hirak , Pelster, Meredith S. , Barve, Minal , Ou, Sai-Hong I, Leal, Ticiana A, Paweletz, Cloud P. , Der-Torossian, Hirak, Klempner, Samuel J , Bekaii-Saab, Tanios S , Spira, Alexander I. , Ou, Sai‐Hong Ignatius , Heavey, Grace A. , Klempner, Samuel J.
New England Journal of Medicine | December 21, 2022 | Volume: 388 | Issue: 1 | Pages: 44-54
